Skip to content
GLP-1 Scorecard
Menu
Graded #447

Emerge Weight Loss

Emerge Weight Loss is a nationwide telehealth platform focused specifically on compounded tirzepatide for medical weight management.

Visit Emerge Weight LossWe may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Semaglutide
Not disclosed
Tirzepatide
$287/mo (2.5 mg dose, compounded)
Coverage
Coverage not published
Brand-name
Compounded only

Line Emerge Weight Loss up against its closest alternatives. Because Emerge Weight Loss dispenses compounded medication, it’s worth understanding whether compounded semaglutide is legit and safe.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value36/100
Dose & formulation42/100
Clinical oversight84/100
Labs & monitoring54/100
Fulfillment70/100
Contract terms55/100

Strengths

  • Tirzepatide-focused (largest effect-size compounded GLP-1)
  • Wide dose range available
  • Physician-supervised telemedicine model

Where it loses points

  • Semaglutide is available only on request — the site and default plans are tirzepatide-only
  • Less brand recognition than Henry Meds, Mochi, or SkinnyRx

Bottom line — Grade C

Best for: Patients committed to tirzepatide as their drug of choice.

Ranked #447 of 499 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.

Closest on the board

The boards grading nearest Emerge Weight Loss — the realistic shortlist.

The 21 boards nearest this one

View full scorecard rankings →

Pricing/verification reflect Emerge Weight Loss's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Emerge Weight Loss's site. Not medical advice; see our disclosure.

← Back to the scorecard